Umphumela wokwelashwa komdlavuza enhliziyweni

Kunemiphumela ethile emibi ye-chemotherapy ne-radiotherapy enhliziyweni yethu ekwelapheni umdlavuza. Xhuma ne- + 91 96 1588 1588 ukwazi kabanzi.

Yabelana ngalokhu okuthunyelwe

Kunemiphumela ethile engemihle ehlobene nezimo zenhliziyo lapho kusetshenziswa imithi yokwelapha umdlavuza njenge-chemotherapy kanye ne-radiotherapy. Lezi zindlela zokwelapha zingase zilimaze inhliziyo, futhi imiphumela yazo engemihle ihlanganisa umfutho wegazi ophakeme, ukushaya kwenhliziyo okungavamile, nokuhluleka kwenhliziyo. Lapho izinto ezinjalo zenzeka, udokotela angase akhethe ukulibazisa, alungise, noma akumise ngokuphelele ukwelashwa. Nokho, eminye yemiphumela emibi yokwelashwa ingase yenzeke ngemva kwesikhathi eside kakhulu futhi ihlale ingabonakali isikhathi esifushane.

Intuthuko yakamuva ku-immunotherapy ukwelashwa komdlavuza Kuye kwaboniswa ukuthi kuhlotshaniswa nengozi yemiphumela yenhliziyo kanye nemiphumela emibi.

Kodwa-ke, ucwaningo olwengeziwe luyadingeka futhi ukusiza ukwazisa izinqumo zomtholampilo mayelana nokwelashwa komdlavuza kanye nemiphumela emibi yenhliziyo. Ngenkathi belapha iziguli ezinomdlavuza, odokotela badinga ukweluleka isiguli ngezinye izindaba zezempilo ezingase zihlotshaniswe nezinkinga zenhliziyo ezifana nesifo sikashukela kanye ne-cholesterol. Ucwaningo olwengeziwe lusendleleni mayelana nalokhu.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-Lutetium Lu 177 dotatate igunyazwe yi-USFDA yeziguli zezingane ezineminyaka engu-12 nangaphezulu nge-GEP-NETS
Cancer

I-Lutetium Lu 177 dotatate igunyazwe yi-USFDA yeziguli zezingane ezineminyaka engu-12 nangaphezulu nge-GEP-NETS

I-Lutetium Lu 177 dotatate, ukwelashwa okuyisimangaliso, isanda kuthola imvume evela kwa-US Food and Drug Administration (FDA) yeziguli zezingane, okumaka ingqopha-mlando ku-oncology yezingane. Lokhu kugunyazwa kumelele ukukhanya kwethemba ezinganeni ezilwa nezimila ze-neuroendocrine (NETs), uhlobo lomdlavuza oluyivelakancane kodwa oluyinselele oluvame ukufakazela ukumelana nemithi evamile.

I-Nogapendekin alfa inbakicept-pmln igunyazwe yi-USFDA yomdlavuza wesinye ongasabeli we-BCG ongaphenduli.
Umdlavuza wesibeletho

I-Nogapendekin alfa inbakicept-pmln igunyazwe yi-USFDA yomdlavuza wesinye ongasabeli we-BCG ongaphenduli.

“I-Nogapendekin Alfa Inbakicept-PMLN, i-immunotherapy enoveli, ibonisa isithembiso ekwelapheni umdlavuza wesinye uma kuhlanganiswa nokwelashwa kwe-BCG. Le ndlela yokusungula iqondise izimpawu ezithile zomdlavuza ngenkathi isebenzisa impendulo yamasosha omzimba, ithuthukisa ukusebenza kahle kwemithi yokwelapha yendabuko efana ne-BCG. Izivivinyo zemitholampilo zembula imiphumela ekhuthazayo, ekhombisa imiphumela ethuthukisiwe yesiguli kanye nentuthuko engaba khona ekulawuleni umdlavuza wesinye. Ukusebenzisana phakathi kwe-Nogapendekin Alfa Inbakicept-PMLN kanye ne-BCG kumemezela inkathi entsha yokwelashwa komdlavuza wesinye.”

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton